Synaptic Medical Corporation
$89.1K 11 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
CashFlow Solutions, LLC
CashFlow Solutions, LLC reported $89,170.43 across General Payments, Research, and Ownership to 1,358 physicians and teaching hospitals across 1,358 transactions.
- $89.2K Below-median payer
- All-tracks total
- 1,358 Top quartile volume
- Transactions
- 1,358 Top quartile reach
- Recipients
- −$30.2K
- General Payments vs PY2023
CashFlow Solutions, LLC reported $89,170.43 across all CMS Open Payments tracks (General + Research + Ownership) to 1,358 physicians and teaching hospitals in Program Year 2024 - ranking #1214 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $89,170.43, averaging $65.66 per recipient.
CashFlow Solutions, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
22/100
Total payments
F
11/100
Transaction volume
F
20/100
Physician reach
F
20/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer cashflow-solutions-llc CashFlow Solutions, LLC
$89.2K · #1214/1,925 · 0.0% industry · PY2024
- TOT $89.2K
- RANK #1214
- SHARE 0.0%
- TXN 1,358
- RCP 1,358
- CAT 3
- GEN $89.2K
- ΔGEN −$30.2K
- TOP1 40.4%
- PY 2024
Volume peers
Nearest volume peer: Synaptic Medical Corporation ($89.1K)
CashFlow Solutions, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
CashFlow Solutions, LLC's CMS-reported General Payments decreased by $30.2K (−25.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CASHFLOW SOLUTIONS, LLCPY2023: CASHFLOW SOLUTIONS, LLCPY2024: CashFlow Solutions, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $119,369.34
- PY2024
- $89,170.43
What the Data Shows for CashFlow Solutions, LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For CashFlow Solutions, LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Consulting Fee" leads the 3-category general-payment breakdown below at $36.0K (40.4% of General Payments, 12 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
CashFlow Solutions, LLC made 3 types of general payments. "Consulting Fee" is the largest category at $36.0K, 40.4% of General Payments.
How CashFlow Solutions, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $36.0K | 12 | 40.4% |
| Long-Term Medical Supply or Device Loan | $33.4K | 21 | 37.5% |
| Food and Beverage | $19.8K | 1,325 | 22.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $50,642.43 (56.8%) of $89,170.43 in this company's General Payments records across 1,058 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for CashFlow Solutions, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Karen Louise Herbst
$36,000.00 across 12 reported transactions
- 2
Cape Fear Valley Medical Center
$4,507.61 across 1 reported transactions
- 3
William Hampton Pasley
$3,977.87 across 3 reported transactions
- 4
Ascension Seton Medical Center
$3,156.85 across 1 reported transactions
- 5
Texoma Medical Center
$3,000.10 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
CashFlow Solutions, LLC ranks #1214 of 1,925 by total payments (bottom 37% by spend) but is notably more concentrated than that alone would suggest -- #804 of 1,838 by HHI (top 44% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Brixton Biosciences, Inc. : $36.4K total payments, HHI 1756
- Sysmex America, Inc. : $54.4K total payments, HHI 1755
- bluebird bio, Inc. : $208.3K total payments, HHI 1750
- Pfizer International LLC : $197.5K total payments, HHI 1747
- NextStep Arthropedix, LLC : $125.7K total payments, HHI 1747
- Greiner Bio-One North America, Inc. : $11.6K total payments, HHI 1746
- CashFlow Solutions, LLC (this company) : $89.2K total payments, HHI 1745
- Acumed LLC : $3.4M total payments, HHI 1742
- Thermo Fisher Scientific Asheville LLC : $2.2K total payments, HHI 1739
- Albireo Pharma, Inc. : $317.2K total payments, HHI 1739
- Puma Biotechnology, Inc. : $396.8K total payments, HHI 1733
- Pulse Biosciences, Inc. : $534.8K total payments, HHI 1730
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as CashFlow Solutions, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about CashFlow Solutions, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with CashFlow Solutions, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
STRATA Skin Sciences, Inc.
$89.3K 2,465 recipients
Compare payment profiles
Thommen Medical USA, LLC
$89.6K 414 recipients
Compare payment profiles
Pinnacle, Inc
$89.6K 1,188 recipients
Compare payment profiles
Change Healthcare Technologies, LLC
$89.9K 55 recipients
Compare payment profiles
Analog Devices Inc.
$88.0K 98 recipients
Compare payment profiles
Put this to use
CashFlow Solutions, LLC ranks #1214 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just CashFlow Solutions, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.